Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
Background For patients with MS, medication switches increase the risk of disease reactivation. Objective Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. Methods Al...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2021-06-01
|
| シリーズ: | Multiple Sclerosis Journal - Experimental, Translational and Clinical |
| オンライン･アクセス: | https://doi.org/10.1177/20552173211022027 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|